Samlyn Capital’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Samlyn Capital’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-616,040	Closed	-$2.05M	–	175
2016 Q3	$2.05M	Sell	616,040 -2	-0%	-$8	0.05%	111
2016 Q2	$2.65M	Hold	616,042	–	–	0.07%	104
2016 Q1	$3.47M	Hold	616,042	–	–	0.08%	83
2015 Q4	$10.6M	Hold	616,042	–	–	0.22%	75
2015 Q3	$13M	Buy	616,042 +11,390	+2%	+$390K	0.24%	78
2015 Q2	$29.9M	Buy	604,652 +290,799	+93%	+$17.4M	0.5%	74
2015 Q1	$24.6M	Sell	313,853 -255,219	-45%	-$15.8M	0.4%	77
2014 Q4	$34.5M	Buy	569,072 +339,172	+148%	+$17M	0.61%	65
2014 Q3	$9.79M	Buy	+229,900	New	+$12.3M	0.21%	86

Other funds holding OREX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return